MedTrace Logo

Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI)

NCT01361815 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2020-07-15

No results posted yet for this study

Summary

The purpose of the study is to explore the Tolerability and Safety of the H-Coil deep Transcranial Magnetic Stimulation (TMS) in combination with Serotonin Selective Reuptake Inhibitor (SSRI) for Subjects with Major Depression Disorder (MDD) who Complete/ Discontinued the Deep TMS Multicenter study for Subjects with Major Depression Disorder (MDD) (Protocol# CTP-0001-00).

Conditions

  • Major Depressive Disorder, Recurrent, Unspecified
  • Major Depressive Disorder, Single Episode, Unspecified

Interventions

DEVICE

H-Coil Deep TMS in combination with SSRIs

The study group will receive DTMS treatment three times a week for four weeks in combination with SSRI medications.

Sponsors & Collaborators

  • Brainsway

    lead INDUSTRY

Principal Investigators

  • Abraham Zangan, Prof. · Weizmann Institute of Science

  • Yechiel Levkovitz, Prof. · Shalvata Mental Health Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
68 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States
  • Canada
  • Germany
  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01361815 on ClinicalTrials.gov